Melissa Sorosina

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

Lifespan Modeling of Choroid Plexus Volume in Multiple Sclerosis and Its Dynamic Associations With Clinical, MRI, and HLA Susceptibility.

Lifespan Modeling of Choroid Plexus Volume in Multiple Sclerosis and Its Dynamic Associations With Clinical, MRI, and HLA Susceptibility.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: June 02, 2026

Pharmacogenomics of response to interferon-beta and glatiramer acetate in Multiple Sclerosis: A multi-centric study.

Pharmacogenomics of response to interferon-beta and glatiramer acetate in Multiple Sclerosis: A multi-centric study.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: March 03, 2026

Distinct age-related pattern of mitochondrial somatic mutations across multiple sclerosis phenotypes.

Distinct age-related pattern of mitochondrial somatic mutations across multiple sclerosis phenotypes.

Journal: Journal of neurology

Published: February 09, 2026

Long Non-Coding RNAs in Multiple Sclerosis-Differential Expression and Functional Implications.

Long Non-Coding RNAs in Multiple Sclerosis-Differential Expression and Functional Implications.

Journal: Genes

Published: September 12, 2025

Environmental risk factors and conversion to multiple sclerosis in subjects with radiologically isolated syndrome: a case-control study.

Environmental risk factors and conversion to multiple sclerosis in subjects with radiologically isolated syndrome: a case-control study.

Journal: Journal of neurology

Published: September 10, 2025

A HIF1A variant impacts long-term disability and smoldering inflammation in multiple sclerosis.

A HIF1A variant impacts long-term disability and smoldering inflammation in multiple sclerosis.

Journal: Acta neuropathologica

Published: September 02, 2025

Correction: Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association study.

Correction: Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association study.

Journal: Journal of neurology

Published: May 27, 2025

Contribution of Polygenic Scores to Progression Independent of Relapse Activity in Multiple Sclerosis.

Contribution of Polygenic Scores to Progression Independent of Relapse Activity in Multiple Sclerosis.

Journal: European journal of neurology

Published: January 31, 2025

Sex hormone-related factors and the risk of PIRA in women with multiple sclerosis.

Sex hormone-related factors and the risk of PIRA in women with multiple sclerosis.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: November 29, 2024

Vitamin D affects the risk of disease activity in multiple sclerosis.

Vitamin D affects the risk of disease activity in multiple sclerosis.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: April 16, 2024

Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association study.

Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association study.

Journal: Journal of neurology

Published: April 15, 2024

Genetic Contribution to Medium-Term Disease Activity in Multiple Sclerosis.

Genetic Contribution to Medium-Term Disease Activity in Multiple Sclerosis.

Journal: Molecular neurobiology

Published: March 12, 2024

Showing 1-12 of 56

Last Updated: 09/26/2026